On September 27, 2019 Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T cell immunotherapy, reported that Christina Coughlin, MD, PhD, Executive Vice President and Chief Medical Officer, and members of the management team plan to participate at the Cantor Fitzgerald 2019 Global Healthcare Conference in New York City on October 3, 2019 (Press release, Tmunity Therapeutics, SEP 27, 2019, View Source [SID1234539859]). The company will webcast a presentation on Tmunity at 4:45 p.m. ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!